Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 AUPH Q1 2026 Earnings EPS Surges Past Estimates Stock Slides Despite Strong BottomLine Performance ESP Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance MTA Q1 2026 Earnings Narrowly Positive EPS Despite Significant Miss SHIP Q4 2025 Earnings EPS Surpasses Estimates by 163 as Stock Slips on Broader Market Sentiment Magnite Inc MGNI Q1 2026 Earnings EPS Surpasses Estimates by 206